The Scientist, in collaboration with Biosearch Technologies, invited Kary Mullis to reflect back on these 30 years in terms of his initial discovery, how things stand today, and where he thinks PCR is headed in the future.
An introduction to the webinar conducted by the periodical to celebrate 30 years of polymerase chain reaction (PCR) invention is presented.Perkel, Jeffrey M.Scientist
1、PCR past, present and future;网页链接 2、The Story of PCR;网页链接 3、Making PCR:a story of biotechnology by Paul Rainbow 4、各公司官网及公开信息、知乎专栏91725264。 ---The End--- 欢迎扫码添加编辑微信号,加入行业交流群 欢迎点击关注 喜欢就一键三连,点赞,在看,分享!
1、PCR Market Forecast and Perspectives 2022. SDI, October 2022. 2、PCR past, present and future ,https://www.future-science.com/doi/10.2144/btn-2020-0057 3、文中部分信息和数据来源:仪器信息网、IVD从业者、IVD研习社、头豹研究院、灼识咨询、杭州博日&苏...
3.PCR past, present and future;https://doi.org/10.2144/btn-2020-0057 关于BioBro大师兄 BioBro大师兄是一个聚焦生物医药领域产学研的共享平台,包括专业交流以及干货内容和供应链信息分享,持续关注细胞治疗、基因治疗、干细胞药物、抗体药物等领域的前沿进展。致力于推动行业内企业和上下游供应链体系高效率良性发展...
4.Zhu H, Zhang H, Xu Y, et al. PCR past, present and future. Biotechniques. 2020;69(4):317-325. 5.Floc'h N, Martin MJ, Riess JW, et al. Antitumor Activity of Osimertinib, an Irreversible Mutant-Sele...
4.Zhu H, Zhang H, Xu Y, et al. PCR past, present and future. Biotechniques. 2020;69(4):317-325. 5.Floc'h N, Martin MJ, Riess JW, et al. Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions. ...
^Michael R Green;Joseph Sambrook.Polymerase Chain Reaction[J].Cold Spring Harbor protocols.2019(2). ^Hanliang Zhu,Haoqing Zhang,Ying Xu.,et al.PCR past,present and future[J].BioTechniques.2020.69(4):317-345.
et al. DNA sequencing at 40: past, present and future. Nature 550, 345–353 (2017). Article ADS CAS PubMed Google Scholar Mardis, E. R. DNA sequencing technologies: 2006–2016. Nat. Protoc. 12, 213–218 (2017). Article CAS PubMed Google Scholar Le Gallo, M., Lozy, F. & ...
[7]Hanliang Zhu,Haoqing Zhang,Ying Xu.,et al.PCR past,present and future[J].BioTechniques.2020.69(4):317-345. 泛生子(纳斯达克代码:GTH)是全球前沿的癌症精准医疗公司,专注癌症基因组学的研究和应用,提供癌症早期筛查、用药指导、预后及监测、肿瘤新药研发服务等...